( OTCMKTS: CPMD ) CannaPharmaRx On December 19th, 2022, they announced that they had secured original genetic strains of cannabis for its declaration. This declaration gets submitted to Health Canada and will permit the new strands to other licensed manufacturers. The Company expects this to be one of the concluding steps before their first harvesting, […]
The post CPMD : On Track for Significant Growth and Revenue appeared first on All Finance Times.
Disclaimer
This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of CannaPharmaRx Inc (CPMD) and does not buy, sell, or trade any shares of (CPMD). This article does not provide a professional analysis of a (CPMD) financial position. (CPMD) financial position and all other information regarding the featured Company should be verified directly with (CPMD). Please read our full disclaimer for more detailed information.
